| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $1.64 (Beat by $0.24) |
| EPS GAAP Actual | $1.64 (Beat by $0.24) |
| Revenue Actual | $2.89475B |
| Revenue Surprise | Beat by $2894.75M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.35 |
| EPS GAAP Estimate | $1.35 |
| Revenue Estimate | $2.4013B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 6.89 | 20.4 | 6.36505 | 7.31881 | 1 |
| Dec 2027 | 6.5 | 21.62 | 5.85692 | 7.16426 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.64 | 0.417 | 2.89475B | -3.64% | 575.35M |
| FQ2 2025 (Jun 2025) | 1.35 | 0.073 | 2.65189B | 8.03% | 332.49M |
| FQ1 2025 (Mar 2025) | 1.48 | 0.3735 | 2.66642B | 17.24% | 480.62M |
| FQ4 2024 (Dec 2024) | 1.69 | 0.41455 | 2.9547B | 22.91% | 524.11M |
| FQ3 2024 (Sep 2024) | 1.63 | 1.63 | 3.00013B | 27% | 3000.13M |
| FQ2 2024 (Jun 2024) | 1.24 | 1.24 | 2.439B | 8.17% | 2439M |
| FQ1 2024 (Mar 2024) | 1.18 | 1.18 | 2.20668B | -17.49% | 2206.68M |
| FQ4 2023 (Dec 2023) | 1.09 | 1.09 | 2.27777B | -51.09% | 2277.77M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.35
Consensus Revenue Estimates
2.4013B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.58 | -- | 1.47086 | 1.66414 | 1 |
| FQ3 2027 (Sep 2027) | 1.64 | -- | 1.52672 | 1.72734 | 1 |
| FQ2 2027 (Jun 2027) | 1.54 | -- | 1.43363 | 1.62201 | 1 |
| FQ1 2027 (Mar 2027) | 1.43 | -- | 1.33122 | 1.50616 | 1 |
| FQ4 2026 (Dec 2026) | 1.42617 | -- | 1.28778 | 1.62718 | 5 |
| FQ3 2026 (Sep 2026) | 1.595 | -2.82 | 1.46833 | 1.74936 | 3 |
| FQ2 2026 (Jun 2026) | 1.4025 | 3.74 | 1.29112 | 1.53823 | 4 |
| FQ1 2026 (Mar 2026) | 1.35 | -9.63 | 1.25654 | 1.46793 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.12B | -- | 2.95B | 3.25B | 2 |
| FQ3 2027 (Sep 2027) | 3.14B | -- | 2.97B | 3.27B | 2 |
| FQ2 2027 (Jun 2027) | 2.83B | -- | 2.68B | 2.95B | 2 |
| FQ1 2027 (Mar 2027) | 2.77B | -- | 2.62B | 2.88B | 2 |
| FQ4 2026 (Dec 2026) | 2.92B | -- | 2.7B | 3.24B | 3 |
| FQ3 2026 (Sep 2026) | 3.1B | 6.77 | 2.92B | 3.34B | 4 |
| FQ2 2026 (Jun 2026) | 2.76B | 3.77 | 2.59B | 2.96B | 4 |
| FQ1 2026 (Mar 2026) | 2.4B | -11.04 | 2.27B | 2.56B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.223 | 1.64 | 0.417 | 25.43% |
| FQ2 2025 (Jun 2025) | 1.277 | 1.35 | 0.073 | 5.41% |
| FQ1 2025 (Mar 2025) | 1.1065 | 1.48 | 0.3735 | 25.24% |
| FQ4 2024 (Dec 2024) | 1.27545 | 1.69 | 0.41455 | 24.53% |
| FQ3 2024 (Sep 2024) | 1.63 | 1.63 | 100% | |
| FQ2 2024 (Jun 2024) | 1.24 | 1.24 | 100% | |
| FQ1 2024 (Mar 2024) | 1.18 | 1.18 | 100% | |
| FQ4 2023 (Dec 2023) | 1.09 | 1.09 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $2.32B | $2.89B | $575.35M | 19.88% |
| FQ2 2025 (Jun 2025) | $2.32B | $2.65B | $332.49M | 12.54% |
| FQ1 2025 (Mar 2025) | $2.19B | $2.67B | $480.62M | 18.02% |
| FQ4 2024 (Dec 2024) | $2.43B | $2.95B | $524.11M | 17.74% |
| FQ3 2024 (Sep 2024) | $0B | $3B | $3000.13M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2.44B | $2439M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2.21B | $2206.68M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $2.28B | $2277.77M | 100% |